Ticarcillin disodium salt CAS:4697-14-7
Ticarcillin disodium salt is indicated for the treatment of severe infections such as pneumonia, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and septicemia caused by susceptible organisms. It is often used in combination with beta-lactamase inhibitors like clavulanic acid to enhance its spectrum of activity and overcome bacterial resistance mechanisms. The dosage and administration of ticarcillin disodium salt depend on the type and severity of the infection, as well as individual patient factors such as renal function and susceptibility of the causative organism. It is typically administered intravenously at regular intervals under medical supervision. Patients should be monitored closely for signs of allergic reactions, including rash, fever, and anaphylaxis, particularly in individuals with a history of penicillin allergy. Prolonged use may lead to the development of superinfections or bacterial resistance, necessitating periodic reassessment of therapy. Consultation with a healthcare professional is essential for personalized treatment recommendations, monitoring for adverse effects, and guidance on managing drug interactions to ensure safe and effective use of ticarcillin disodium salt in bacterial infections.
Composition | C15H17N2NaO6S2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 4697-14-7 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |